Outstanding Clinical Investigator Award
Christos Mantzoros, MD, DSc
Christos Mantzoros, MD, DSC, an extraordinarily productive investigator, is currently the chief of the Nutrition Unit at Beth Israel Deaconess Medical Center and chief of the Endocrine Section at the VA Boston Healthcare System. Dr. Mantzoros serves as a full professor of medicine at Harvard Medical School and has served as a professor in environmental health at the School of Public Health. He is also the editor-in-chief of Metabolism (impact factor: 5.78).
He is a true innovator and a leader in the field of metabolism, as evidenced by the novel findings he has published, the novel compounds he has developed, the successful companies he has co-founded, and his excellent track record of funding over the past two decades. His translational work has elucidated the pharmacokinetics and physiology of leptin in humans and has contributed toward its approval by the FDA and other agencies internationally, has elucidated the role of adiponectin and the IGF system in malignancies, and has propelled forward the development of the insulin sensitizer CHRS-131, currently in Phase III clinical trials. Most recently, he has been studying the physiology of novel adipokines, myokines, and gastrointestinal tract-secreted hormones with potential implications in metabolic diseases. In addition, he has been advancing our understanding of the beneficial effects of Mediterranean diet through clinical epidemiology studies and by leading the translation of these discoveries to public health benefits through Pangea Inc., which he co-founded.
He is a true innovator and a leader in the field of metabolism, as evidenced by the novel findings he has published, the novel compounds he has developed, the successful companies he has co-founded, and his excellent track record of funding over the past two decades.
Dr. Mantzoros has published over 725 scientific articles in high-quality journals such as Nature, JCI, NEJM, including 190 peer-reviewed reviews and chapters. The reach and impact of his work is evidenced by the more than 28,200 citations (plus 5,000 citations from the Look Ahead Study) with an H index of 88 in Thompson Reuters and more than 46,000 citations with an H index of 112 in Google Scholar.
Loading ...